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In the “GFP reconstitution across synaptic partners” (GRASP) method, non-fluorescent
fragments of GFP are expressed in two different neurons; the fragments self-assemble
at synapses between the two to form a fluorophore. GRASP has proven useful for light
microscopic identification of synapses in two invertebrate species, Caenorhabditis elegans
and Drosophila melanogaster, but has not yet been applied to vertebrates. Here, we
describe GRASP constructs that function in mammalian cells and implement a transgenic
strategy in which a Cre-dependent gene switch leads to expression of the two fragments
in mutually exclusive neuronal subsets in mice. Using a transgenic line that expresses
Cre selectively in rod photoreceptors, we demonstrate labeling of synapses in the outer
plexiform layer of the retina. Labeling is specific, in that synapses made by rods remain
labeled for at least 6 months whereas nearby synapses made by intercalated cone
photoreceptors on many of the same interneurons remain unlabeled. We also generated
antisera that label reconstituted GFP but neither fragment in order to amplify the GRASP
signal and thereby increase the sensitivity of the method.
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INTRODUCTION
Analysis of neural circuits requires identification of neurons
that are synaptically connected to each other. A major imped-
iment to mapping these connections is that many neurites in
the central nervous system are too small to be resolved by
conventional light microscopy: synaptic sites can be visualized
but the neurites from which they arise cannot be identified
unambiguously. At present, therefore, connectivity is gener-
ally assessed by electron microscopic and electrophysiological
methods. Both of these techniques are extremely laborious,
however, and both are difficult to apply when the pre- and post-
synaptic somata are separated by long-distances. Accordingly,
many groups have sought improved light microscopic meth-
ods for circuit analysis, and three have shown considerable
promise. The first is super-resolution microscopy, sometimes
called nanoscopy, in which even the most slender neurites can
be resolved (Huang et al., 2010). The second is transsynap-
tic tracing, in which genetically encoded labels are secreted at
synaptic sites and selectively internalized by the apposed pre- or
postsynaptic membrane (Horowitz et al., 1999; Yoshihara et al.,
1999; Wickersham et al., 2007; Lo and Anderson, 2011). The
third is “GFP Reconstitution Across Synaptic Partners” or GRASP
(Feinberg et al., 2008).
GRASP is based on the use of non-fluorescent fragments
of GFP that can be fused to other proteins, yet retain the
ability to self-assemble and form a fluorophore. This com-
plementation strategy was initially used to detect intracellular
protein-protein interactions (Hu and Kerppola, 2003; Zhang
et al., 2004; Cabantous et al., 2005). To adapt the method for
detection of synapses, Feinberg et al. (2008) used a GFP deriva-
tive that had been engineered for efficient complementation
(“superfolder GFP”; Pedelacq et al., 2006), split it into two frag-
ments (sGFP1–10 and sGFP11), fused them to the ectodomains
of cell surface proteins, and expressed one fusion protein in each
of two neurons in C. elegans that were known to be synaptically
connected. They showed that the fragments reconstituted fluores-
cent GFP specifically at sites of synapses between the two neurons.
Subsequently, Gordon and Scott (2009) and Gong et al. (2010)
used the method to mark synapses in Drosophila.
GRASP is particularly useful because it is the only light micro-
scopic method to date capable of unequivocally marking synaptic
contacts between two genetically specified neurons. We, there-
fore, asked whether it can be applied to mammals. We report here
generation of knock-in mice in which sGFP1–10 and sGFP11 are
fused to components of synaptic membrane proteins, neuroligin
(NLG), and neurexin (NXN) (Südhof, 2008), and expressed in
mutually exclusive neuronal subsets. We demonstrate that GRASP
specifically marks synapses between members of the two subsets
in retina, without marking synapses made by other axons on the
same postsynaptic cells.
MATERIALS AND METHODS
GRASP CONSTRUCTS
We modified the DNA sequence of superfolder GFP (Pedelacq
et al., 2006) by optimizing codon usage for mice and remov-
ing potential splicing donor and acceptor motifs without altering
the encoded amino acid sequence (GenBank accession number
JQ341914). The modified gene was synthesized (DNA2.0, Menlo
Park, CA) and cloned into a backbone derived from CMV-EGFP-
N1 (Clontech, Mountain View, CA). The GFP1–10 and GFP11
fragments were retrieved from this vector by PCR and fused to rat
neuroligin-1 or neurexin-1β (obtained from Alice Ting, MIT), or
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human CD4 (obtained from Evan Feinberg and Cori Bargmann,
Rockefeller University).
CELL LINES
Human embryonic kidney 293 cells (HEK293; ATCC, Manassas,
VA) were subcloned and a derivative was selected that could be
cloned with high efficiency; we call this line 293PL. 293PL cells
in 24-well tissue culture dishes were transfected using DMRIE-C
(Life Technologies, Grand Island, NY), then trypsinized 3 days
later, plated on 10 cm tissue culture dishes, and selected in
1mg/ml G418 (Life Technologies). Colonies were split and tested
by immunostaining for expression of the gene product.More than
70% of the cells in each clone showed high expression of the
introduced gene.
Each clone was cultured to confluency, trypsinized, and plated
onto glass coverslips, either alone or mixed with cells of a
second clone. After 2–3 days, cultures were fixed with 100%
methanol or 4% paraformaldehyde/PBS for 15min at room tem-
perature, then rinsed with PBS. Methanol-fixed cultures had
lower background than paraformaldehyde-fixed cultures, so this
treatment was usually used for detecting native GRASP signals.
For immunostaining, paraformaldehyde cultures were processed
as described previously (Yamagata and Sanes, 2010). Finally,
cultures were mounted with FluoroGel (Electron Microscopy
Sciences, Hatfield, PA) and imaged with a Pascal LSM-510 con-
focal microscope (Zeiss).
Use of stably transfected lines was required for these assays
because co-expression of two complementary split GFP frag-
ments in the same cell leads to efficient cis-reconstitution
that hampers detection of the much lower levels of trans-
reconstitution between apposed cells. Surprisingly, we observed
such co-expression when we mixed populations that had been
transiently transfected with complementary fragments. We sus-
pect that low levels of DNA adhere to cells even when the cells
were trypsinized and rinsed multiple times prior to co-culture.
ANTIBODIES TO GFP
Full length superfolder GFP was cloned into pEcoli-6xHN
(Clontech) and introduced into BL21(DE3) pLysS cells. The cells
were grown in Magic Media (Life Technologies) and processed
with Bugbuster (EMD Chemicals, Philadelphia, PA), and the
GFP was purified with Talon columns (Clontech). Hens were
immunized with the recombinant GFP (Covance), eggs from
immunized hens were harvested, and the IgY fraction from egg
yolk was purified with IgY purification kit (Pierce, Rockford, IL).
To obtain antibody that reacted selectively with holo-GFP, the
sGFP1–10 fragment was expressed in E. coli using pEcoli-6xHN.
This fragment was insoluble, so inclusion bodies were purified,
dissolved with 4M urea (in 50mM TrisHCl, pH 7.4), purified
using Talon columns, and coupled to NHS-Activated Agarose
(Pierce). The anti-GFP IgY was absorbed to this resin and the
non-binding fraction was further absorbed with acetone pow-
der prepared from mouse brain. This purified antibody is called
anti-rGFP.
A hybridoma producing a mouse monoclonal antibody GFP-
G1 (subclass, IgG1) was obtained by immunizing a female
Balb/c mouse. Its splenocytes were fused to FOX-NY myeloma
line, and selected by a standard procedure for generating
hybridomas. Hybridomas were screened by staining tissue
from GFP-expressing mice to obtain an antibody suitable for
immunostaining. One antibody selected, GFP-G1, recognizes all
the GFP derivatives tested (EYFP, Venus, superfolder GFP, and
cerulean). IgG was purified from cultured supernatants using
Protein-G affinity gels (GenScript, Piscataway, NJ).
KNOCK-IN MOUSE LINE
To generate a GRASP knock-in targeting vector, pRosa26-PAS
(Srinivas et al., 2001) wasmodified in the following series of steps.
(1) A phosphorylated i-SceI linker (AGTTACGCTAGGGATAA
CAGGGTAATATAG) was ligated into the SwaI site, producing
a recognition site for linearization of the targeting vector.
(2) A PacI-FRT-neo-FRT-AscI selection cassette was cloned
into pROSA26PAS-i-SceI. (3) A PacI-CAG-RfA-WPRE-PacI
cassette containing the chicken β-actin promoter and CMV
immediate-early enhancer (together called CAG), a Gateway
RfA destination cassette (Gateway Vector Conversion system;
Life Technologies), and a WPRE fragment (woodchuck hepatitis
virus post-transcriptional element) was assembled in a modi-
fied pBluescriptKS+ that had been generated by inserting GA
GCTCAGTTACGCTAGGGATAACAGGGTAATATAGAATTCTT
AATTAAGCGGCCGCGATCGCCCGGGCATTTAAATGGCCTG
CAGGGCCGTTTAAACGGCCGGCCGTCGACTCGAGCGTAA
CTATAACGGTCCTAAGGTAGCGAAGGTACC into the Kpn
I/SacI sites. (4) This cassette was cloned into a PacI site of
pROSA26PAS-FNF-iSceI. (5) sGFP11::NXN was cloned to pCR8-
Topo (Life Technologies) with an appended I-CeuI sequence at
its N-terminus. (6) sGFP1–10::NLG and a polyadenylation signal
were cloned into a modified pBluescript+ that had generated by
inserting CCGGGAGCTCCGTAACTATAACGGTCCTAAGGTA
GCGAATTCTTAATTAAGCGGCCGCGATCGCCCGGGCATTT
AAATGGCCTGCAGGGCCGTTTAAACGGCCGGCCGTCGAC
TCGAGCGTAACTATAACGGTCCTAAGGT AGCGAAGGTACC
GCGC and 2 loxP sites into the KpnI/SacI sites. (7) This sGFP1–
10::NLG with a polyadenylation signal was excised with I-CeuI
and cloned into an I-CeuI site of 11::NXN in pCR8-Topo. (8)
This sGFP-10::NLG-sGFP11-NXN cassette was transferred to the
product of step 4 above using LR clonase (Life Technologies).
The i-SceI linearized vector was electroporated into a 129/B6
F1 hybrid ES cell line, V6.5. G418-resistant, targeted ES clones
were identified by PCR. Correct targeting efficiency was >50%.
ES cell transfections and blastocyst injections were performed
by the Genome Modification Facility, Harvard University. After
germ-line transmission, the FRT-neo-FRT sequence was removed
by crossing to mice that express Flp recombinase ubiquitously
(Farley et al., 2000).
Rhodopsin-Cre transgenic mice (Li et al., 2005) were obtained
from Shiming Chen (Washington University). Animal procedures
were in compliance with the US National Institutes of Health
Guide for the Care and Use of Laboratory Animals and approved
by the Animal and Care and Use Program at Harvard University.
IMMUNOSTAINING
Immunostaining was performed as described by Yamagata
and Sanes (2010). Briefly, tissues were dissected, fixed in 4%
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paraformaldehyde/PBS overnight at 4◦C, sunk in 15% (w/v)
and 30% (w/v) sucrose/PBS, mounted in OCT compound,
and cryosectioned. The sections were treated with 0.1% Triton
X-100/PBS followed by Image-iT FX signal enhancer (Life
Technologies), blocked with 5% skim milk/PBS, incubated with
primary antibodies overnight at 4◦C, rinsed, incubated with
secondary antibodies with Neurotrace 435 (Life Technologies)
overnight at 4◦C, rinsed, and mounted with FluoroGel.
Primary antibodies used were: rabbit anti-Cre (Abcam,
Cambridge, MA); mouse anti-neuroligin-1 and anti-neurexin-1β
(NeuroMab, Davis, CA); mouse anti-bassoon (GeneTex, Irvine,
CA); mouse anti-SV2 (Developmental Studies Hybridoma
Bank, Iowa City, IA), mouse anti-β-dystroglycan (Leica Micro-
systems, Buffalo Grove, IL), mouse anti-PSD95 (Affinity Bio-
reagents, IgG1); monoclonal anti-GFP (GFP-Mab20, Sigma)
and the two anti-GFP antibodies described above. Rhodamine-
conjugated Peanut agglutinin was from Vector Lab (Burlingame,
CA)andsecondaryantibodieswere fromJacksonImmunoresearch
Laboratories (West Grove, PA).
RESULTS
GRASP BETWEEN CULTURED MAMMALIAN CELLS
Superfolder GFP (Pedelacq et al., 2006) was designed for use in
E. coli. To improve expression in mammalian cells, we optimized
its codon usage for mice (GenBank, JQ341914), and fused the
sGFP1–10 and sGFP11 fragments to mammalian transmembrane
cell surface proteins: human CD4 glycoprotein with a cytoplas-
mically fused monomeric cherry, rat neurexin-1β (NXN) and
rat neuroligin-1 (NLG; Figure 1A). The CD4-cherry fusion has
been used for GRASP in C. elegans (Feinberg et al., 2008) and
Drosophila (Gordon and Scott, 2009), and NXN and NLG are
localized to the pre- and postsynaptic membranes, respectively,
of most mammalian synapses (Südhof, 2008; Shen and Scheiffele,
2010).
The six fusions were introduced into HEK293PL cells and
stably transfected populations were selected, passaged and cul-
tured either alone or in pairwise combinations. We observed no
reconstituted GFP fluorescence when any one of the six popu-
lations was cultured alone or in most combinations (Figure 1
and Table 1). In only two cases were contacts between cells
fluorescent, indicating reconstitution of GFP in mixtures of
sGFP1–10::NLG cells with sGFP11::NXN cells and in mixtures
of sGFP1–10::NXN cells with sGFP11::NLG cells (Figure 1D and
Table 1). GRASP signal was readily detectable in live cells viewed
with an inverted microscope, supporting the possibility that
the technique could be used to image synapses in live tissue.
Immunolabeling with antibodies to NXN and NLN confirmed
that in each case, signal was present only at contacts between
FIGURE 1 | GRASP signals in cultured mammalian cells.
(A) Superfolder GFP fragments sGFP1–10 and sGFP11 were fused to
mammalian transmembrane proteins neurexin (NXN), neuroligin (NLG),
and CD4 for display on the cell surface. Assembly of sGFP1–10 with sGFP11
reconstitutes fluorescent GFP. (B–D) 293 cells stably transfected with either
1–10::NLG (B) or 11::NXN (C) show no GRASP fluorescence. However,
GRASP signal was observed at contacts between sGFP1–10::NLG- and
sGFP11::NXN-expressing cells (D). (D’) shows the outline of cells in
(D). (E–G) No complementation was detected with CD4 fusions.
Bar: 10μm.
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Table 1 | GRASP signal at cell-cell contacts of various configurations.
1–10::NLG1 11::NLG1 1–10::NXN 11::NXN 1–10::CD4 11::CD4
1–10::NLG1 − − − + − −
11::NLG1 − − + − − −
1–10::NXN − + − − − −
11::NXN + − − − − −
1–10::CD4 − − − − − −
11::CD4 − − − − − −
Stably transfected 293 cell lines were co-cultured as indicated.
+, GRASP signal was observed; −, GRASP signal was not observed.
NXN-expressing and NLN-expressing cells (data not shown).
The failure to observe complementation between sGFP1–10::CD4
and sGFP11::CD4, was surprising in that these fusions generate
GRASP signals in C. elegans and Drosophila (Feinberg et al., 2008;
Gordon and Scott, 2009).
GENERATION OF GRASP KNOCK-IN MICE
To mark synapses in vivo, we generated mice in which sGFP1–
10::NLG and sGFP11::NXN are expressed in complementary
sets of neurons. Tests in HEK293PL cells had shown that the
two fragments complement efficiently when expressed in the
same cell, resulting in intense signals that prevent detection
of the relatively weak signals resulting from complementation
at opposed membranes between cells (see Methods). To pre-
vent such co-expression, we designed a vector that contained
both fragments, with sGFP1–10::NLG expressed by default and
sGFP11-NXN expressed only following Cre-dependent excision
of sGFP1–10::NLG (Figures 2A,B). The cassette (CAG-LoxP-
sGFP1–10::NLG-pA-LoxP-11:: sGFP11::NXN-pA) was intro-
duced into HEK293PL cells using a piggyBac-transposon
(Yamagata and Sanes, 2008, 2010) to generate a cell line harbor-
ing a single copy. The cells expressed sGFP1–10::NLG but not
sGFP11::NXN. Following transfection with a plasmid encoding
Cre, the cells expressed sGFP11::NXN but not sGFP1–10::NLG
(data not shown).
We then generated mice using this gene switch vector. We
used a knock-in strategy to ensure that the genome contained
only a single copy of the cassette. Thus, any individual cell can
express either sGFP1–10::NLG or sGFP11::NXN, but can never
express both. In contrast, transgenes introduced by oocyte injec-
tion often comprise multiple copies in tandem, so recombination
of only a subset of the copies would lead to cis-complementation.
To maximize levels of expression, we used the strong compos-
ite CAG (CMV + chicken β-actin) promoter-enhancer, added
a WPRE to stabilize mRNA, and inserted the vector into the
ROSA26 locus, which is suitable for ubiquitous expression of
transgenes (Soriano, 1999; Zong et al., 2005;Madisen et al., 2010).
Homologous recombinants were selected and used to generate
germ-line chimeras by standard methods. We call the resulting
line mGRASP1.
For initial tests, we used a transgenic line that expresses
Cre recombinase specifically in rod photoreceptors under con-
trol of regulatory elements from the rhodopsin gene (Li et al.,
2005). Immunostaining for Cre recombinase confirmed the
specificity of the transgene (Figures 2D,H). We expected that
sGFP1–10::NLG would be broadly expressed and sGFP11-::NXN
would be undetectable in mGRASP1 mice, whereas sGFP11-
NXN would be expressed only in rods, and sGFP1–10::NLG
would be expressed in all other retinal cells in double trans-
genic mGRASP1; rhodopsin-Cre mice (Figure 2C). Indeed, in
mGRASP1 mice, NLG immunoreactivity was present through-
out the retina, including in photoreceptor outer segments
(Figure 2E). NLG immunoreactivity was barely detectable in
wild-type retina (data not shown), indicating that the signal in
mGRASP1 mice reflected expression of sGFP1–10::NLG. Little
NXN reactivity was detected in retinas of wild-type or mGRASP1
mice. In mGRASP1; rhodopsin-Cre mice, NLG immunoreac-
tivity was lost from outer retina, confirming loss of sGFP1–
10::NLG (Figures 2E,I). Likewise, immunostaining with NXN
confirmed accumulation of sGFP11::NXN in the outer plexiform
layer of mGRASP1; rhodopsin-Cre mice (Figures 2L,M). Most
important, complementation led to appearance of GRASP sig-
nal in the outer plexiform layer of mGRASP1 (Figures 2F,G,J,K);
rhodopsin-Cre mice; this is layer in which axon terminals of
photoreceptors form synapses on dendrites of bipolar and hori-
zontal cells (Rao-Mirotznik et al., 1995; Sterling and Matthews,
2005).
IMMUNOAMPLIFICATION OF GRASP SIGNALS
Although GRASP signals in mGRASP1; rhodopsin-Cre mice were
clear and specific, they were weak. We attempted to enhance the
signal using a commercially available monoclonal antibody, GFP-
Mab20, which binds to an epitope present in holo-GFP but not
in either the sGFP1–10 or the sGFP11 fragment (Gordon and
Scott, 2009). This antibody was useful but inadequate, because
it recognizes only a single epitope and therefore, provides limited
amplification, and also because anti-mouse secondary antibodies
lead to non-specific staining of mouse tissues. We, therefore, gen-
erated polyclonal antisera to native GFP, and purified from the
sera those antibodies that recognized native GFP but not sGFP1–
10 (see Methods and Figures 3A–D). The purified antibodies
specifically recognized reconstituted GFP at borders between
cells transfected with sGFP1–10::NLG and sGFP11::NXN cells,
whereas a monoclonal antibody to GFP, which we also generated,
recognized both the reconstituted GFP and the sGFP1–10::NLG
fragment (Figures 3E–G). We used the holo-GFP-specific anti-
body, which we call anti-rGFP, for further characterization of
mGRASP1 mice.
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FIGURE 2 | Generation of GRASP knock-in mice. (A) Targeting construct
for generation of mGRASP1 mice. sGFP1–10::NLG was placed between
LoxP sites, followed by sGFP11::NXN. WPRE, Woodchuck post-transcriptional
regulatory element; pA, polyadenylation signal. FRT-SV40-neo-FRT and DTX
denote selection cassettes used for positive and negative selection of
correctly targeted ES cells, respectively; these cassettes were absent from
the final mGRASP1 line. (B) Cre recombinase deletes sGFP1–10::NLG,
thereby activating expression of sGFP11::NXN. (C) Diagram of gene
switching in retina. sGFP1–10::NLG is expressed in all cells of mGRASP1
mice (top). Following cross to rhodopisin-Cre, mice, expression of
sGFP1–10::NLG is extinguished in rod photoreceptors but persists in other
cells; concurrently, expression of sGFP11::NXN is activated specifically in rod
photoreceptors. (D–G) Sections of retina from P30 mGRASP mice. (D,E)
Sections stained with anti-Cre (D), and anti-NLG (E). Neurotrace 435
counterstain is blue. No Cre is detectable, but NLG immunoreactivity is
present throughout the retina. Because NLG immunoreactivity is barely
detectable in wild-type retina (not shown). signal in (E) is due to
sGFP1–10::NLG. Note strong signal associated with photoreceptor outer
segments (arrowheads in E). (F,G) No GRASP signals are detectable in retina.
(G) shows high-power view of OPL from area boxed in (F). (H–K) Sections of
retina from P30 mGRASP; rhodopsin-Cre mice. (H,I) Sections stained with
anti-Cre (H), anti-NLG (I), and Neurotrace 435 (blue). Cre is abundant in
photoreceptor nuclei in the ONL (H) and NLG immunoreactivity is lost from
photoreceptor outer segments (arrowheads in I). (J,K) GRASP signals are
detectable in OPL. (K) shows high-power view of area boxed in (J). (L,M)
Sections of retina from P30 mGRASP; rhodopsin-Cre mice were stained with
anti-NLG (L) and anti-NXN (M). NXN is concentrated in nerve terminals in the
OPL. Because NXN immunoreactivity is barely detectable in wild-type retina
(not shown), signal in (M) is due to sGFP11::NXN. Bar, 10μm for D,E,H,I;
5μm for F,J; 2.5μm for G,K–M. ONL, outer nuclear layer; OPL, outer
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL,
ganglion cell layer.
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FIGURE 3 | Amplification of GRASP signal using antibodies recognizing
reconstituted GFP. (A,B) Superfolder GFP is fluorescent when expressed in
293 cells (A) whereas split GFP1–10 is not (B). Chicken antibodies to
bacterially expressed superfolder GFP recognize both proteins (A’,B’). Blue
channel shows counter-staining with Neurotrace 435. (C,D) Following
absorption to sGFP1–10 and tissue, the same antibodies react with
fluorescent superfolder GFP (C,C’), but not sGFP1–10 (D,D’). (E,F) Mouse
monoclonal antibody Mab GFP-G1 recognizes both superfolder GFP (E) and
split GFP1–10 (F). (G,G’) Cells transfected with 1–10::NLG or 11::NXN were
co-cultured and doubly stained with Mab GFP-G1 and chicken anti-rGFP. Mab
GFP-G1 stained the sGFP1–10::NLG expressing cell. In contrast, anti-rGFP
stains only contacts between sGFP1–10::NLG- and sGFP11::NXN-expressing
cells (mab GFP-G1-positive and -negative, respectively). Bar, 20μm for A–F;
5μm for (G).
CHARACTERIZATION AND SPECIFICITY OF GRASP SIGNALS IN
PHOTORECEPTOR SYNAPSES
To test whether the GRASP signal in the outer plexiform layer of
mGRASP1; rhodopsin-Cre mice is localized to rod synapses, we
double-labeled sections with anti-rGFP plus antibodies to synap-
tic components. Bassoon marks active zones in photoreceptor
nerve terminals (Brandstätter et al., 1999). GRASP signals abutted
Bassoon-positive puncta (Figures 4A,B). In one set of sections
from P60 retina, we found that 73 ± 4% of Bassoon-positive
puncta in the OPL were anti-rGFP-positive. This is an under-
estimate, because Bassoon marks cone as well as rod synapses
and the latter are unlabeled (see below). In many cases, a pair of
GRASP-positive puncta were localized directly adjacent to a larger
Bassoon-positive punctum. In these triplets, the Bassoon-positive
structure was generally closer to the outer nuclear layer, in which
photoreceptors reside, while the rGFP-positive puncta were closer
to the inner nuclear layer, which contains horizontal and bipolar
cells. It is known that each rod synapse comprises a presynaptic
rod terminal, invaginating processes from two horizontal cells,
and a central bipolar process; the horizontal cell processes directly
about the photoreceptor membrane whereas the bipolar process
does not (Figure 4I; also see Rao-Mirotznik et al., 1995; Sterling
andMatthews, 2005). Thus, the pattern we observed suggests that
GRASP signalsmark direct contacts between the rod terminal and
the horizontal processes. Lack ofGRASP signal associatedwith the
bipolar process is consistent with the idea that directly abutting
membranes are required for assembly of sGFP1–10 with sGFP11.
We also stained sections with antibodies to PSD95 and β-
dystroglycan. In many central synapses, PSD95 is associated with
the postsynaptic membrane, but in photoreceptor synapses it is
localized in perisynaptic areas within photoreceptor nerve ter-
minals, adjacent to active zones (Koulen et al., 1998; Yamagata
and Sanes, 2010). Likewise, β-dystroglycan is present in expanded
portions of photoreceptor terminals, but not at active zones
(Blank et al., 1999). Double labeling revealed that rGFP-positive
puncta were near PSD95- and β-dystroglycan-positive puncta
(Figures 4C–F). These patterns support the idea that GRASP
signals line rod nerve terminals.
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FIGURE 4 | GRASP signal in OPL is confined to rod synapses.
Sections from retina of double transgenic mGRASP1; rhodopsin-Cre mice
were double-stained with anti-rGFP plus anti-bassoon (A,B), anti-PSD95
(C,D), anti-β-dystroglycan (E,F) or peanut agglutinin (PNA, G,H). (B,D,F,H)
show high-power images from fields shown in (A,C,E,G), respectively.
(I) is a sketch of a rod photoreceptor synapse. (A,B) Pairs of GFP-positive
puncta are apposed to sites labeled with anti-Bassoon, which marks active
zones in rod terminals (red spot in I). This arrangement suggests that GRASP
signals are present at synaptic contacts made by rod terminals onto two
invaginating horizontal cell processes (I). Blue color shows Neurotrace 435.
(C,D) GFP-positive puncta are apposed to sites labeled with anti-PSD95,
which marks perisynaptic regions widely within rod terminals. (E,F)
GFP-positive puncta are apposed to sites labeled with anti-β-dystroglycan,
which marks perisynaptic regions within rod terminals. β-dystroglycan is also
present in cone terminals (c). (G,H) GFP-positive puncta are absent from
sites labeled with Peanut agglutinin-positive, which marks cone
photoreceptors terminals (c). This arrangement suggests that GRASP signals
are present at synapses of rod but not cone photoreceptors on horizontal
and bipolar cell processes. (I) A sketch of a rod spherule. Two horizontal
cell dendrites (h) directly contact a rod terminal, and a bipolar dendrite (b)
is distant from a synaptic ribbon. Bar, 3μm for A,C,E,G; 1μm for
B,D,F,H.
Finally, we asked whether GRASP signals are confined to
synapses made by rod photoreceptors onto horizontal cells, or
whether they are also present at closely apposed synapses made
by cone photoreceptors on the same horizontal cells. In mice,
95–97% of photoreceptors are rods, and only 3–5% are cones,
so if GRASP signals were not confined to appropriate synapses
on horizontal cells we would expected them to be present in
nearby cone synapses. To mark cone pedicle synapses, we incu-
bated sections with peanuts agglutinin (PNA), which labels cone
but not rod terminals in mouse retina (Blanks and Johnson,
1983). GRASP signals were excluded from PNA-positive struc-
tures (Figures 4G,H), indicating that the method can distinguish
synapses made by two different presynaptic cells onto the same
postsynaptic cell.
LONG-TERM EXPRESSION OF MAMMALIAN GRASP SYSTEM
The GRASP method generates a transsynaptic link that is
not present endogenously. It is, therefore, a concern that the
long-term presence of this link could affect synaptic structure.
Moreover, our implementation of the GRASP method requires
expression of NXN and NLG both of what can affect synapse
number when overexpressed (Chubykin et al., 2007; Dahlhaus
et al., 2010). We, therefore, analyzed the number and molecu-
lar architecture of rod photoreceptor synapses in 7 month-old
mGRASP1; rhodopsin-Cre mice. The presence of GRASP links
over this prolonged period had no detectable effect on the lev-
els or localization of any synaptic marker tested, including SV2,
bassoon, PSD95, and β-dystroglycan (Figure 5). In addition, the
number of photoreceptor terminals (bassoon-positive puncta)
in the OPL of 7 month-old retinas did not differ significantly
between mice expressing both mGRASP and Rhodopsin-Cre, and
controls expressing only Rhodopsin-Cre (8.9 ± 2.3 and 9.1 ± 2
puncta/100μm2, respectively; p > 0.1 by t-test). Thus, long-term
expression of GRASP linkages at synapses has no detectable effect
on the persistence or molecular architecture of these synapses.
DISCUSSION
We have shown that the GRASP method, which was originally
developed to detect synaptic connections in C. elegans (Feinberg
et al., 2008), can also be used to detect synapses in mice. As a
test, we labeled synapses between rod photoreceptors and their
postsynaptic partners, horizontal cells; we showed that labeling
is specific in that synapses made by cone receptors on the same
postsynaptic partners were unlabeled.
While we were preparing this work for publication, Kim et al.
(2012) described an alternative method for implement GRASP
in mice. They, like us, found that fusing fragments to NXN
and NLG was effective whereas fusions to CD4 were ineffective.
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FIGURE 5 | Prolonged expression of GRASP has no obvious effect on
the molecular architecture of photoreceptor synapses. (A–E) OPL of
7 month-old control mice were stained with anti-rGFP (A) and antibodies
to synaptic markers: bassoon at active zones (B), SV2 in synaptic vesicles
(C), and PSD95 and β-dystroglycan in regions of nerve terminal
membrane abutting active zones (D,E). (F–J) OPL of 7 month-old
mGRASP1; rhodopsin-Cre mouse, stained as in (A–E).
Bar, 2μm.
In our cases, GRASP signals from CD4 fusions were unwork-
able faint, whereas for Kim et al. (2012), signals were detectable
but not synaptically localized. Whereas we used a transgenic
strategy to express the split GFP fragments, they used a viral
strategy. A major advantage of the transgenic strategy is that
labeling is completely non-invasive whereas a major advantage of
the viral strategy is that post- as well as presynaptic cells can be
selected. Another difference between the methods is that whereas
we used unmodified NXN and NLG, they mutated NLG to pre-
vent strong interactions with NXN, which, as noted above, might
affect synaptic size or strength (Chubykin et al., 2007; Dahlhaus
et al., 2010). Although we have noted no ill effects of overexpres-
sion, it may be more prudent to adopt the strategy of Kim et al.
(2012) in the future.
Together the two sets of results make a strong case that GRASP
will be generally useful for circuit analysis in mice. First, both
transgenic (this paper) and viral methods (Kim et al., 2012)
can be used to deliver GRASP components. Second, both light
(this paper) and electron microscopic (Kim et al., 2012) methods
demonstrate the specificity of GRASP labeling. Third, marking of
synapses in retina (this paper) and forebrain (Kim et al., 2012)
indicate that the method can be applied to multiple synaptic
types.
The major drawback to our instantiation of the GRASP
method is that it is insufficiently sensitive. Although signals
in photoreceptor synapses are robust, these are especially large
synapses, and we have not been able to consistently detect sig-
nals at smaller synapses in the inner plexiform layer of the retina,
the spinal or the cortex using other Cre transgenic lines. We sus-
pect that this limitation reflects the relatively low expression of the
postsynaptic partner, sGFP1–10::NLG in mGRASP1 mice. This,
in turn, may result from fact that the WPRE in the construct,
which greatly enhances expression (Madisen et al., 2010) would
be expected to stabilize the mRNA encoding sGFP11::NXN but
not that encoding sGFP1–10::NLG. In addition, our experience
with gene transfer methods in vivo suggests that the viral and
electroporation methods used by Kim et al. (2012) lead to consid-
erably higher levels of expression than does the knock-in method
we used. To circumvent this limitation, and thereby expand the
range of applications for the method, we are currently engineer-
ing transgenes in which both components are expressed at higher
levels.
ACKNOWLEDGMENTS
We thank the Genome Modification at Harvard University for
generating germ-line chimeras, Dr. Shiming Chen for providing
rhodopsin-Cre mice on behalf of Dr. Jason Chen, and Dr. Evan
Feinberg for valuable comments. This work was supported by
the Gatsby Foundation, NIH (U24NS063931), and Collaborative
Innovation Award #43667 from HHMI.
REFERENCES
Blank, M., Koulen, P., Blake, D. J., and
Kröger, S. (1999). Dystrophin and
beta dystroglycan in photoreceptor
terminals from normal andmdx3Cv
mouse retinae. Eur. J. Neurosci. 11,
2121–2133.
Blanks, J. C., and Johnson, L. V. (1983).
Selective lectin binding of the
developing mouse retina. J. Comp.
Neurol. 221, 31–41.
Brandstätter, J. H., Fletcher, E. L.,
Garner, C. C., Gundelfinger, E. D.,
and Wässle, H. (1999). Differential
expression of the presynaptic
cytomatrix protein bassoon among
ribbon synapses in the mam-
malian retina. Eur. J. Neurosci. 11,
3683–3693.
Cabantous, S., Terwilliger, T. C., and
Waldo, G. S. (2005). Protein tag-
ging and detection with engineered
self-assembling fragments of green
fluorescent protein. Nat. Biotechnol.
23, 102–107.
Chubykin, A. A., Atasoy, D., Etherton,
M. R., Brose, N., Kavalali, E. T.,
Gibson, J. R., and Südhof, T.
C. (2007). Activity-dependent
validation of excitatory versus
inhibitory synapses by neuroligin-1
versus neuroligin-2. Neuron 54,
919–931.
Dahlhaus, R., Hines, R. M., Eadie,
B. D., Kannangara, T. S., Hines,
D. J., Brown, C. E., Christie, B.
R., and El-Husseini, A. (2010).
Overexpression of the cell adhesion
protein neuroligin-1 induces learn-
ing deficits and impairs synaptic
plasticity by altering the ratio of
excitation to inhibition in the
hippocampus. Hippocampus 20,
305–322.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 18 | 8
Yamagata and Sanes Mammalian GRASP
Farley, F. W., Soriano, P., Steffen, L.
S., and Dymecki, S. M. (2000).
Widespread recombinase expres-
sion using FLPeR (flipper) mice.
Genesis 28, 106–110.
Feinberg, E. H., Vanhoven, M. K.,
Bendesky, A., Wang, G., Fetter,
R. D., Shen, K., and Bargmann,
C. I. (2008). GFP Reconstitution
Across Synaptic Partners (GRASP)
defines cell contacts and synapses in
living nervous systems. Neuron 57,
353–363.
Gong, Z. F., Liu, J. Q., Guo, C.,
Zhou, Y. Q., Teng, Y., and Liu, L.
(2010). Two pairs of neurons in
the central brain control Drosophila
innate light preference. Science 330,
499–502.
Gordon, M. D., and Scott, K. (2009).
Motor control in a Drosophila taste
circuit. Neuron 61, 373–384.
Horowitz, L. F., Montmayeur, J. P.,
Echelard, Y., and Buck, L. B. (1999).
A genetic approach to trace neural
circuits. Proc. Natl. Acad. Sci. U.S.A.
96, 3194–3199.
Hu, C. D., and Kerppola, T. K. (2003).
Simultaneous visualization of
multiple protein interactions in
living cells using multicolor fluo-
rescence complementation analysis.
Nat. Biotechnol. 21, 539–545.
Huang, B., Babcock, H., and Zhuang,
X. (2010). Breaking the diffraction
barrier: super-resolution imaging of
cells. Cell 143, 1047–1058.
Kim, J., Zhao, T., Petralia, R. S.,
Yu, Y., Peng, H., Myers, E., and
Magee, J. C. (2012). mGRASP
enables mapping mammalian
synaptic connectivity with light
microscopy. Nat. Methods 9,
96–102.
Koulen, P., Fletcher, E. L., Craven, S.
E., Bredt, D. S., and Wassle, H.
(1998). Immunocytochemical local-
ization of the postsynaptic density
protein PSD-95 in the mammalian
retina. J. Neurosci. 18, 10136–10149.
Li, S., Chen, D., Sauvé, Y., McCandless,
J., Chen, Y. J., and Chen, C. K.
(2005). Rhodopsin-iCre transgenic
mouse line for cre-mediated rod-
specific gene targeting. Genesis 41,
73–80.
Lo, L., and Anderson, D. J. (2011).
A cre-dependent, anterograde
transsynaptic viral tracer for map-
ping output pathways of genetically
marked neurons. Neuron 72,
938–950.
Madisen, L., Zwingman, T. A., Sunkin,
S. M., Oh, S. W., Zariwala, H. A.,
Gu, H., Ng, L. L., Palmiter, R. D.,
Hawrylycz, M. J., Jones, A. R., Lein,
E. S., and Zeng, H. (2010). A robust
and high-throughput cre reporting
and characterization system for the
whole mouse brain. Nat. Neurosci.
13, 133–140.
Pedelacq, J. D., Cabantous, S., Tran, T.,
Terwilliger, T. C., and Waldo, G. S.
(2006). Engineering and character-
ization of a superfolder green fluo-
rescent protein. Nat. Biotechnol. 24,
79–88.
Rao-Mirotznik, R., Harkins, A. B.,
Buchsbaum, G., and Sterling, P.
(1995). Mammalian rod terminal:
architecture of a binary synapse.
Neuron 14, 561–569.
Shen, K., and Scheiffele, P. (2010).
Genetics and cell biology of building
specific synaptic connectivity. Annu.
Rev. Neurosci. 33, 473–507.
Soriano, P. (1999). Generalized lacZ
expression with the ROSA26 Cre
reporter strain. Nat. Genet. 21,
70–71.
Srinivas, S., Watanabe, T., Lin, C. S.,
William, C. M., Tanabe, Y., Jessell,
T. M., and Costantini, F. (2001). Cre
reporter strains produced by tar-
geted insertion of EYFP and ECFP
into the ROSA26 locus. BMC Dev.
Biol. 1, 4.
Sterling, P., and Matthews, G. (2005).
Structure and function of ribbon
synapses. Trends Neurosci. 28,
20–29.
Südhof, T. C. (2008). Neuroligins and
neurexins link synaptic function
to cognitive disease. Nature 455,
903–911.
Wickersham, I. R., Lyon, D. C.,
Barnard, R. J., Mori, T., Finke,
S., Conzelmann, K. K., Young, J.
A., and Callaway, E. M. (2007).
Monosynaptic restriction of
transsynaptic tracing from sin-
gle, genetically targeted neurons.
Neuron 53, 639–647.
Yamagata, M., and Sanes, J. R. (2008).
Dscam and Sidekick proteins direct
lamina-specific synaptic connec-
tions in vertebrate retina. Nature
451, 465–469.
Yamagata, M., and Sanes, J. R. (2010).
Synaptic localization and function
of Sidekick recognition molecules
require MAGI scaffolding proteins.
J. Neurosci. 30, 3579–3588.
Yoshihara, Y., Mizuno, T., Nakahira,
M., Kawasaki, M., Watanabe,
Y., Kagamiyama, H., Jishage, K.,
Ueda, O., Suzuki, H., Tabuchi, K.,
Sawamoto, K., Okano, H., Noda,
T., and Mori, K. (1999). A genetic
approach to visualization of mul-
tisynaptic neural pathways using
plant lectin transgene. Neuron 22,
33–41.
Zhang, S., Ma, C., and Chalfie, M.
(2004). Combinatorial marking of
cells and organelles with reconsti-
tuted fluorescent proteins. Cell 119,
137–144.
Zong, H., Espinosa, J. S., Su, H.
H., Muzumdar, M. D., and Luo,
L. (2005). Mosaic analysis with
double markers in mice. Cell 121,
479–492.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 14 January 2012; accepted:
03 February 2012; published online: 16
February 2012.
Citation: Yamagata M and Sanes JR
(2012) Transgenic strategy for identi-
fying synaptic connections in mice by
fluorescence complementation (GRASP).
Front. Mol. Neurosci. 5:18. doi: 10.3389/
fnmol.2012.00018
Copyright © 2012 Yamagata and Sanes.
This is an open-access article dis-
tributed under the terms of the Creative
Commons Attribution Non Commercial
License, which permits non-commercial
use, distribution, and reproduction in
other forums, provided the original
authors and source are credited.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 18 | 9
